Epidemiology of chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 17, Issue 5, 2001, Pages 982-994

  Anto J M ^a   Vermeire, P ^a   Vestbo, J ^a   Sunyer, J ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

1 Antitrypsin deficiency; Chronic obstructive pulmonary disease; Epidemiology; Passive smoking; Smoking

Indexed keywords

ALPHA 1 ANTITRYPSIN; OXYGEN; STEROID;

ADULT; AGED; AIR POLLUTION; ARTICLE; ATOPY; BRONCHUS REACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DETERIORATION; DIET; DISABILITY; DISEASE COURSE; DISEASE PREDISPOSITION; DYING; DYSPNEA; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; GENETIC VARIABILITY; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INDUSTRIALIZATION; INFLUENZA VACCINATION; MALE; MORTALITY; OCCUPATION; OXYGEN THERAPY; PASSIVE SMOKING; PHENOTYPE; PRIORITY JOURNAL; REHABILITATION; RESPIRATORY FAILURE; RISK; RISK FACTOR; SMOKING; SMOKING CESSATION; SOCIAL STATUS; SPIROMETRY; STATISTICS; SURVIVAL RATE; SYMPTOM;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CROSS-CULTURAL COMPARISON; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; RISK FACTORS; UNITED STATES;

EID: 0034948984     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17509820     Document Type: Article

References (149)

1. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
2. Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
3. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
4. Incidence, prevalence and mortality: Intra- and intercountry differences
5. Prevalence of chronic obstructive pulmonary disease in blacks
6. Epidemiology: A British Perspective
7. Blood pressure and respiratory function
8. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): Prevalence of chronic respiratory symptoms and airflow limitation
9. Chronic obstructive lung disease in Copenhagen: Cross-sectional epidemiological aspects
10. Prevalence of obstructive lung disease in a general population: Relation to occupational title and exposure to some airborne agents
11. Clinically "small" effects of air pollution on FVC have a large public health impact
12. International comparisons in COPD mortality
13. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data
14. Trends in chronic obstructive pulmonary disease mortality in Australia
15. Evidence-based health policy-lessons from the Global Burden of Disease Study
16. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry
17. Development of impaired lung function: Natural history and risk factors
18. Epidemiology of chronic obstructive pulmonary disease
19. Decline of FEV1 by age and smoking status: Facts, figures, and fallacies
20. Rapidly decreasing forced expiratory volume in one second or vital capacity and development of chronic airway obstruction
21. An index of risk for obstructive airways disease
22. Value of chemoprophylaxis for chronic bronchitis
23. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men
24. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity
25. The natural history of chronic airflow limitation
26. The relationship between pulmonary function and dyspnea in obstructive lung disease
27. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire
28. Chronic obstructive pulmonary diesase stage and health-related quality of life
29. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
30. Health status deterioration in patients with chronic obstructive pulmonary disease
31. Quality of life and hospital-readmission in patients with chronic obstructive pulmonary disease
32. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
33. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
34. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease
35. Outcomes following acute exacerbation of severe chronic obstructive lung disease
36. Chronic mucus hypersecretion in COPD and death from pulmonary infection
37. The relation of chronic diseases to all-cause mortality risk - The Seven Countries Study
38. Prognosis in chronic obstructive pulmonary disease
39. Vital prognosis after hospitalization for COPD. A study of a random population sample
40. Relationship of constitutional factors and smoking to decrease in 1-second forced expiratory volume
41. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease
42. Does right ventricular function predict survival in patients with chronic obstructive pulmonary disease?
43. Causes of death in patients with COPD and chronic respiratory failure
44. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease
45. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease and all causes in the Witheall study
46. The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms
47. Variables associated with changes in spirometry in patients with obstructive lung diseases
48. The relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes
49. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital
50. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive disease
51. Mortality in the London fog incident
52. Air pollution and exacerbation of bronchitis
53. 2 levels and acute illness in patients with chronic bronchopulmonary disease
54. Air pollution and health in three urban communities
55. Do present levels of air pollution outdoors affect respiratory health?
56. Increased mortality in Philadelphia associated with daily air pollution concentrations
57. Short-term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: Results from the APHEA project
58. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project
59. Air pollution and hospital admissions for the elderly in Birmingham, Alabama
60. Air pollution and hospital admissions for the elderly in Detroit, Michigan
61. PM10, ozone, and hospital admissions for the elderly in Minneapolis-St Paul, Minnesota
62. Air pollution and hospital admissions for respiratory disease
63. Air pollution and hospital admissions in Sydney, Australia, 1990 to 1994
64. Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: A case-crossover analysis
65. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994
66. Harvesting and long term exposure effects in the relation between air pollution and mortality
67. Genetic risk factors for chronic obstructive pulmonary disease
68. Longitudinal lung function study in heterozygous PiMZ phenotype subjects
69. Risk of hospital admission for obstructive pulmonary disease in alpha 1-antitrypsin heterozygotes of phenotype PiMZ
70. Microsatellite DNA instability in COPD
71. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease
72. Effects of cigarette smoking on the pulmonary function in adolescent boys and girls
73. Sex and race differences in the development of lung function
74. Importance of detailed adjustment for smoking when comparing morbidity and mortality in men and women in a Danish population study
75. Gender difference in smoking effects on lung function and risk for hospitalization for COPD. Results from a Danish longitudinal population study
76. Gender-related differences in severe, early-onset COPD
77. Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function
78. Airways responsiveness and development and remission of chronic respiratory symptoms in adults
79. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: A cohort study
80. Rate of decline of lung function in subjects with asthma
81. A 15-year follow-up of ventilatory function in adults with asthma
82. Sex-specific effects of asthma on pulmonary function in children
83. Mortality in adults with self-reported bronchial asthma. A study of the general population
84. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: The Normative Aging Study
85. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second
86. Summary of parental smoking on the effects of parental smoking on the respiratory health of children and implications for research
87. The urban factor in chronic bronchitis
88. Decreases in FVC and FEV1 with time: Indicators for effects of smoking and air pollution
89. X, and hydrocarbons
90. Lung function and long term exposure to air pollutants in Switzerland
91. 2 in eight areas of Switzerland
92. Long-term particulate and other air pollutants and lung function in non-smokers
93. Air pollution and childhood respiratory health: Exposure to sulfate and ozone in 10 Canadian rural communities
94. Health effects of acid aerosols on North American children: Pulmonary function
95. A study of twelve southern California communities with different levels and types of air pollution. Effects on pulmonary function
96. The adverse effect of low levels of ambient air pollutants on lung function growth in preadolescent children
97. Association between air pollution and lung function growth in southern California children
98. Lung function growth and ambient ozone. A three year population study in school children
99. Air pollution and other local factors in respiratory disease
100. Smoking, air pollution and bronchitis in Britain
101. Chronic nonspecific respiratory disease, Bertin NH, 1961-1967. A cross sectional study
102. The incidence and severely of acute respiratory illness in families exposed to different levels of air pollution. New York Metropolitan Area, 1971-1972
103. Relationship of symptoms of chronic bronchitis and emphysema to matter and air pollution
104. Chronic non-specific respiratory diseases in the city of Cracow
105. Chronic obstructive pulmonary disease symptom effects of long-term cumulative exposure to ambient levels of total suspended particulates and sulfur dioxide in California Seventh-day Adventist residents
106. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study)
107. An association between air pollution and mortality in six US cities
108. Particulate air pollution as a predictor of mortality in a prospective study of US adults
109. Long-term ambient concentrations of total suspended particulates and oxidants as related to incidence of chronic disease in California preadolescent children
110. Long-term inhalable particles and other air pollutants related to mortality in non-smokers
111. Occupation and chronic obstructive pulmonary disease
112. Occupational exposure and 25-year incidence of nonspecific lung disease: The Zutphen Study
113. Occupational exposures estimated by a population specific job exposure matrix and 25 year incidence rate of chronic nonspecific lung disease (CNSLD): The Zutphen Study
114. Guidelines for reading literature reviews
115. Occupational dust exposure and chronic obstructive lung disease
116. Ventilatory function and winter fresh fruit consumption in a random sample of British adults
117. Dietary factors and their relation to respiratory symptoms
118. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample
119. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease
120. Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study
121. Role of polyunsaturated fatty acids in lung disease
122. Socioeconomic status and chronic obstructive pulmonary disease
123. Socioeconomic status, lung function, and admission to hospital for COPD. Results from the Copenhagen City Heart Study
124. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow study
125. Socioeconomic status and lung function among primary school children in Canada
126. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: A Norwegian community study
127. The relationship of socio-environmental factors to the prevalence of obstructive lung disease and other chronic conditions
128. Why is chest disease so common in South Wales? Smoking, social class, and lung function: A survey of elderly men in two areas
129. Prevalence and risk factors for chronic bronchitis in Pelotas, Brazil: A population-based study
130. Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women
131. Effects of childhood and adolescence-adulthood respiratory infections in a general population
132. A reexamination of risk factors for ventilatory impairment
133. Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring
134. Fetal lung hypoplasia associated with maternal smoking: A morphometric analysis
135. The effects of maternal smoking during pregnancy on early infant lung function
136. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease
137. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
138. Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study
139. Emerging tobacco hazards in China: 1. Retrospective mortality study of one million deaths
140. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study
141. Inhaled glucocorticoids in chronic obstructive pulmonary disease
142. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial
143. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht. The Netherlands
144. Relation between influenza vaccination and outpatients visits, hospitalization, and mortality in elderly persons with chronic lung disease
145. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
146. Respiratory muscle training in chronic airflow limitation: Meta-analysis